High PTPRZ-B levels, as in glioblastoma cells, thus may lead to decreased ErbB4 activity in two ways; by sequestering PSD95 and preventing PDZ-mediated ErbB4 homodimer formation as well as by directly dephosphorylating ErbB4. This evidence concerns the gene DLG4 and glioblastoma.